Convallamarin

Convallamarin
Names
	Systematic IUPAC name (1β,3β,5β,22R)-3-{[6-Deoxy-4-O-(β-D-glucopyranosyl)-β-D-gulopyranosyl]oxy}-26-(β-D-galactopyranosyloxy)-22-hydroxyfurost-25(27)-en-1-yl 6-deoxy-4-O-(6-deoxy-β-D-gulopyranosyl)-β-D-allopyranoside
Identifiers
CAS Number	1391-12-4;
3D model (JSmol)	Interactive image;
ChemSpider	4884540;
ECHA InfoCard	100.014.298
EC Number	215-728-6;
PubChem CID	23304308;
	InChI InChI=1S/C57H94O27/c1-20(19-74-50-43(68)39(64)36(61)31(17-58)79-50)10-13-57(73)21(2)34-30(84-57)16-29-27-9-8-25-14-26(78-51-46(71)41(66)49(23(4)76-51)83-54-45(70)40(65)37(62)32(18-59)80-54)15-33(56(25,7)28(27)11-12-55(29,34)6)81-52-47(72)42(67)48(24(5)77-52)82-53-44(69)38(63)35(60)22(3)75-53/h21-54,58-73H,1,8-19H2,2-7H3/t21-,22+,23+,24+,25+,26+,27+,28-,29-,30-,31+,32+,33+,34-,35-,36-,37+,38+,39-,40-,41-,42-,43+,44+,45+,46+,47+,48+,49-,50+,51-,52-,53-,54-,55-,56-,57+/m0/s1 Key: PSJVJZYSECBFHJ-BANYBNOTSA-N;
	SMILES O[C@@H]%10[C@H](O)[C@@H](O)[C@H](O[C@H]%10O[C@H]1[C@@H](O)[C@@H](O)[C@@H](O[C@@H]1C)O[C@@H]5C[C@H](O[C@@H]3O[C@H](C)[C@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H]3O)C[C@H]6CC[C@H]4[C@H]9[C@](CC[C@@H]4[C@@]56C)([C@@H]7[C@@H](O[C@@](O)([C@H]7C)CCC(=C)\CO[C@@H]8O[C@H](CO)[C@H](O)[C@H](O)[C@H]8O)C9)C)C;
Properties
Chemical formula	C57H94O27
Molar mass	1211.352 g·mol−1
Appearance	Yellowish-white crystalline powder
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
	Infobox references

Convallamarin[1] is a crystalline glycoside extracted from Convallaria majalis.[2]

References

"CONVALLAMARIN : MP Biomedicals". Archived from the original on 14 July 2011. Retrieved 21 July 2010.
"Materia Medica, General Therapeutics, and Pharmacy". The American Journal of the Medical Sciences. 57 (114): 527–528. April 1869.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.